Moreover, since CTLA-4 binds the ligands CD80 and CD86, we analyzed the expression of these ligands on both TAMs and the tumor cells and found no difference in the expression of these molecules on either macrophages or tumor cells (Supplementary Fig 6i, j). The gene discussed is CD80; the disease is neoplasm.